Eli Lilly licenses non opioid pain med for $40M upfront

Eli Lilly licenses non opioid pain med for $40M upfront

Submitted by admin on March 2, 2023 - 9:58am
Source: 
Seeking Alpha
News Tags: 
Eli Lilly
Confo Therapeutics
non-opioid pain treatments
CFTX-1554
Headline: 
Eli Lilly licenses non opioid pain med for $40M upfront
snippet: 

Belgium-based Confo Therapeutics announced a licensing agreement with Eli Lilly (NYSE:LLY) on Wednesday to grant the pharma giant global rights for its experimental non-opioid pain therapy CFTX-1554 for $40M upfront.

Do Not Allow Advertisers to Use My Personal information